Summary
Patients with metastatic cancer have a permanent shortening of platelet survival and increased platelet consumption. Acetylsalicylic acid or dipyridamole in doses known to inhibit platelet aggregation, had no effect on platelet consumption.
Zusammenfassung
Bei Patienten mit metastasierendem Carcinom ist die Überlebenszeit der Blutplättchen durch gesteigerten Umsatz verkürzt. Acetylsalicylsäure und Dipyridamol in einer für die Plättchenaggregationshemmung ausreichenden Dosis hatten keinen Einfluß auf den Plättchenverbrauch.
Similar content being viewed by others
References
Abrahamsen,A.F.: A modification of the technique for 51Cr labelling of blood platelets giving increased circulating platelet radioactivity. Scand. J. Haemat. 5, 53 (1968)
Abrahamsen,A.F.: The effects of acetylsalicylic acid and dipyridamole on platelet economy in metastatic cancer. Scand. J. Haemat. 9, 562 (1972)
Harker,L.A., Slichter,A.J.: Platelet and fibrinogen consumption in man. New Engl. J.Med. 287, 999 (1972)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Abrahamsen, A.F. Platelet turnover in metastatic cancer and the effect of platelet aggregation inhibitors. Z. Krebsforsch. 86, 109–111 (1976). https://doi.org/10.1007/BF00304941
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00304941